Page 3 - Keith Warner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Neuralace Medical announced today that it received FDA clearance for its chronic painful diabetic neuropathy (PDN) treatment.

RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Robert Keith Warner sold 14,502 shares of RxSight stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $35.01, for a total transaction of $507,715.02. Following the sale, the director now owns 29,248 shares of the company’s stock, valued at […]

RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Robert Keith Warner sold 14,502 shares of the company’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $35.01, for a total value of $507,715.02. Following the completion of the sale, the director now owns 29,248 shares […]

RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Robert Keith Warner sold 5,498 shares of the company’s stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $35.08, for a total transaction of $192,869.84. Following the completion of the transaction, the director now owns 23,750 shares in the […]

TULLY POTTER: Here we go again… just five years after the tawdry Rheingold of Keith Warner last appeared, the prologue to Wagner's Ring cycle has been delivered.